Wanzhen Li (Jing Zhang, J Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 42

Top Venues

Antimicrobial agents and chemotherapy

mSphere

Antibiotics (Basel, Switzerland)

Advances in therapy

Fudan University Huashan Hospital Institute of Antibiotics

Fudan University Huashan Hospital Institute of Antibiotics (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University Huashan Hospital Institute of Antibiotics

China

Professor :: Key Laboratory of Clinical Pharmacology of Antibiotics

Education History

Fudan University Huashan Hospital Institute of Antibiotics

China

PHD

Publications

Wanqiu Yang, Kaiting Zhang, Yuancheng Chen, Yaxin Fan, Wanzhen Li
Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere 9 (3) (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere 9 (3) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Wanqiu Yang, Kaiting Zhang, Yuancheng Chen, Yaxin Fan, Wanzhen Li
Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere 9 (3) (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere 9 (3) (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Xingyi Qu, Chenxue Guo, Shaojun Liu, Xin Li, Lin Xi, Xiao-Fen Liu, Wanzhen Li
Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 13 (4) (2024)
Haijing Yang, Yi Jin, Hailin Wang, Hong Yuan, Jingjing Wang, Size Li, Yingying Hu, Huahui Yang, Xin Li, Hong Liang, Jufang Wu, Guoying Cao, Wanzhen Li
Erratum for Yang et al., "A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects". Antimicrobial agents and chemotherapy (2024)
Size Li, Xu Zhu, Guoying Cao, Jufang Shen, Xu Zhu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Haijing Yang, Nanyang Li, Yingying Hu, Jingjing Wang, Haihui Huang, Wanzhen Li
Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects. Antimicrobial agents and chemotherapy (2024)
Xingyi Qu, Chenxue Guo, Shaojun Liu, Xin Li, Lin Xi, Xiao-Fen Liu, Wanzhen Li
Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 13 (4) (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy (2024)
Wanzhen Li, Xiaolan Huang, Dan Li, Xiao-Fen Liu, Xiaoying Jiang, Xingchen Bian, Xin Li
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae . mSphere 9 (3) (2024)
Haijing Yang, Yi Jin, Hailin Wang, Hong Yuan, Jingjing Wang, Size Li, Yingying Hu, Huahui Yang, Xin Li, Hong Liang, Jufang Wu, Guoying Cao, Wanzhen Li
A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects. Antimicrobial agents and chemotherapy (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Zhiwei Huang, Xinyi Yang, Yi Jin, Jicheng Yu, Guoying Cao, Jingjing Wang, Yingying Hu, Jingyi Dai, Jufang Wu, Qiong Wei, Yan Tian, Shuyan Yu, Xu Zhu, Xiaomeng Mao, Wei Liu, Hong Liang, Shansong Zheng, Yunfei Ju, Zenghua Wang, Wanzhen Li, Xiaojie Wu
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects. Antimicrobial agents and chemotherapy (2023)
Na Wang, Yuan-Cheng Chen, Xingyi Qu, Xingchen Bian, Jiali Hu, Xiaogang Xu, Li Xiao, Yang Liu, Wanzhen Li
In vitro pharmacodynamics of nemonoxacin and other antimicrobial agents against Mycoplasma pneumoniae . Microbiology spectrum (2023)
Yaxin Fan, Kaiting Zhang, Mengting Chen, Nanyang Li, Xiao-Fen Liu, Minjie Yang, Xiaoyu Liang, Jufang Wu, Beining Guo, Huajun Zheng, Yongqiang Zhu, Fengying Zhang, Jingqing Hang, Huifang Zhang, Ruilan Wang, Qing Yuan, Xiaolian Song, Shengbin Wu, Bo Shen, Wanzhen Li
Comparative efficacy of vancomycin in treating ST5 and ST764 methicillin-resistant Staphylococcus aureus infections in adult patients. mSphere (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Yuran Cao, Xiaojie Wu, Zhiqiang Wang, Yuxian Huang, Junzhen Wu, Guoying Cao, Jicheng Yu, Jingjing Wang, Haijing Yang, Wenhong Zhang, Wanzhen Li
Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects. Antimicrobial agents and chemotherapy 67 (3) (2023)
Xingyi Qu, Xingchen Bian, Yuancheng Chen, Jiali Hu, Xiaolan Huang, Yu Wang, Yaxin Fan, Hailan Wu, Xin Li, Yi Li, Beining Guo, Xiaofen Liu, Wanzhen Li
Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla OXA-23 -harboring CRAB in In Vitro PK/PD Model. Molecules (Basel, Switzerland) 27 (3) (2022)
Chuhan Zhang, Xiao-Fen Liu, Hailan Wu, Yu Wang, Yaxin Fan, Beining Guo, Xingchen Bian, Xin Li, Wanzhen Li
Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis. Microbiology spectrum 10 (2) (2022)
Ya-Xin Fan, Meng-Ting Chen, Nan-Yang Li, Xiao-Fen Liu, Min-Jie Yang, Yuan-Cheng Chen, Xiao-Yu Liang, Ju-Fang Wu, Bei-Ning Guo, Si-Chao Song, Yong-Qiang Zhu, Feng-Ying Zhang, Jing-Qing Hang, Sheng-Bin Wu, Bo Shen, Hua-Yin Li, Qin Wang, Xu-Ming Luo, Qing-Ge Chen, Hui-Fang Zhang, Rui-Lan Wang, Li-Hua Shen, Feng-Ming Fu, Xiao-Lian Song, Wanzhen Li
Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin. Microbiology spectrum 10 (5) (2022)
Haijing Yang, Min Zhang, Yuancheng Chen, Hong Ren, Hong Zhang, Chen Yu, Jianda Lu, Li You, Jicheng Yu, Hong Liang, Cuilan Xiao, Zishuang He, Jufang Wu, Jun Xue, Wanzhen Li
Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment. European journal of clinical pharmacology 78 (7) (2022)
Hong Yuan, Hailan Wu, Yingyuan Zhang, Haihui Huang, Yi Li, Junzhen Wu, Guoying Cao, Jicheng Yu, Beining Guo, Jufang Wu, Zhengyu Yuan, Yuan-Cheng Chen, Wanqiu Yang, Xiaojie Wu, Wanzhen Li
Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections. Antimicrobial agents and chemotherapy 66 (6) (2022)
Yingjie Zhou, Wanzhen Li, Yuan-Cheng Chen, Jufang Wu, Beining Guo, Xiaojie Wu, Yingyuan Zhang, Minggui Wang, Ru Ya, Hao Huang
Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Ya-Xin Fan, Yuan-Cheng Chen, Yi Li, Ji-Cheng Yu, Xing-Chen Bian, Xin Li, Wan-Zhen Li, Bei-Ning Guo, Hai-Lan Wu, Xiao-Fen Liu, Yu Wang, Xiao-Yong Xu, Jia-Li Hu, Jing-Jing Wang, Xiao-Jie Wu, Guo-Ying Cao, Ju-Fang Wu, Chun-Jia Xue, Jun Feng, Ying-Yuan Zhang, Wanzhen Li
Effects of Different Component Contents of Colistin Methanesulfonate on the Pharmacokinetics of Prodrug and Formed Colistin in Human. Pharmaceutical research 38 (1) (2021)
Xiaojie Wu, Jian Meng, Hong Yuan, Dafang Zhong, Jicheng Yu, Guoying Cao, Xingdang Liu, Beining Guo, Yuan-Cheng Chen, Yi Li, Yaoguo Shi, Mikhail F Gordeev, Jufang Wu, Wanzhen Li
Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development. Antimicrobial agents and chemotherapy 65 (11) (2021)
Yi Li, Jianda Lu, Yue Kang, Xiaoyong Xu, Xin Li, Yuancheng Chen, Kun Wang, Xiaofen Liu, Yaxin Fan, Hailan Wu, Yu Wang, Jiali Hu, Jicheng Yu, Jufang Wu, Beining Guo, Yingyuan Zhang, Xin Zeng, Ming Zhao, Jun Xue, Wanzhen Li
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysis. British journal of clinical pharmacology (2021)
Yaxin Fan, Yu Wang, Mengting Chen, Yuan-Cheng Chen, Beining Guo, Xiaofen Liu, Hailan Wu, Yi Li, Jiali Hu, Wanzhen Li
Degradation of vancomycin in external quality assessment samples is a factor to underestimate its concentration. Bioanalysis (2021)
Jinjie He, Guoying Cao, Jicheng Yu, Jingjing Wang, Nengneng Cheng, Jufang Wu, Wanzhen Li, Xiaojie Wu, Basheng Zhang, Jiayan Lu, Shangzhi Chen
Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects. Clinical drug investigation 41 (1) (2020)
Xiaofen Liu, Zhenwei Yu, Yu Wang, Hailan Wu, Xingchen Bian, Xin Li, Yaxin Fan, Beining Guo, Wanzhen Li
Therapeutic drug monitoring of polymyxin B by LC-MS/MS in plasma and urine. Bioanalysis 12 (12) (2020)
Junzhen Wu, Kun Wang, Yuancheng Chen, Hong Yuan, Li Li, Wanzhen Li
Concentration-response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent. Journal of pharmacokinetics and pharmacodynamics 46 (6) (2019)
G Cao, X Liang, Wanzhen Li, Y Zhou, J Wu, Y Zhang, Y Chen, J Huang, X Liu, J Yu
Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis. Journal of clinical pharmacy and therapeutics 40 (6) (2015)

Wanzhen Li.css-eqlu8i{font-size:small;padding-left:4px;} (Jing Zhang, J Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Wanzhen Li (Jing Zhang, J Zhang)